Home > News > Capsulution Nanoscience on the Upswing
February 22nd, 2007
Capsulution Nanoscience on the Upswing
Abstract:
Good times for nanotechnology companies. The Berlin-based Capsulution Nanoscience AG fulfilled its turnover expectations in 2006 with more than 1.3 million euro. In comparison to the year before, the developers of nanotechnological "active component packages" managed with this an increase of about 50%. The personnel figures rose to a final 20 members of staff, more than half of which are highly-qualified scientists and laboratory staff in the field of research and development.
Source:
verivox.de
Bookmark:
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Working backward: Computer-aided design of zeolite templates: Rice scientists apply drug-design lessons to production of industrial minerals June 17th, 2013
An Innovative material for the Green Earth: Simple and inexpensive process to make a material for CO2 adsorption June 17th, 2013
Financial Reports
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013
Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013
Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013